title: Increase in rapid defibrillation programmes after publication of guidelines.
abstract: OBJECTIVE
  . To monitor the implementation of in-hospital resuscitation strategies including (i) rapid defibrillation programmes, (ii) the use of amiodarone for prolonged ventricular fibrillation, and (iii) uniform data collection on resuscitation, all recommended by international guidelines published in 2000 and by Finnish national resuscitation guidelines published in 2002.
  
  
  METHODS
  In 2004, a questionnaire was sent to the chief anaesthesiologists. The results were compared with those of a previous study performed using similar methods in 2000.
  
  
  METHODS
  All public hospitals that provide anaesthetic services in Finland.
  
  
  METHODS
  Number of hospitals allowing nurses to perform defibrillation without the presence of physician and number of hospitals using amiodarone as primary antiarrhythmic drug in resuscitation and performing uniform data collection.
  
  
  RESULTS
  The response rate was 95% (52/55). The proportion of the hospitals with rapid defibrillation programmes on general wards had increased from 15% in 2000 to 67% in 2004, and most (79%) hospitals had obtained automated external defibrillators. Amiodarone was used in 88% of the hospitals. Data collection of resuscitation attempts using definitions provided in the Utstein guidelines was performed only in 22% of the hospitals.
  
  
  CONCLUSIONS
  Rapid defibrillation programmes have markedly increased, and the use of amiodarone has been established in Finnish hospitals since the publication of the international and the national resuscitation guidelines.
authors.affiliation: Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland. jouni.nurmi@helsinki.fi
authors.forename: Jouni
authors.initials: J
authors.lastname: Nurmi
authors.forename: Markus B
authors.initials: MB
authors.lastname: Skrifvars
authors.forename: Per H
authors.initials: PH
authors.lastname: Rosenberg
authors.forename: Maaret
authors.initials: M
authors.lastname: Castrén
mesh_terms: D016223:Advance Directives; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D016887:Cardiopulmonary Resuscitation / Q000592:standards*; D004554:Electric Countershock / Q000592:standards*; D005387:Finland; D019983:Guideline Adherence; D006779:Hospitals, Public; D006801:Humans; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care; D011795:Surveys and Questionnaires
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone